Cryo-Cell International, Inc. (CCEL)

NYSEAMERICAN: CCEL · Real-Time Price · USD
6.64
+0.39 (6.24%)
Apr 3, 2025, 4:00 PM EST - Market closed
6.24%
Market Cap 53.67M
Revenue (ttm) 31.99M
Net Income (ttm) 402,095
Shares Out 8.08M
EPS (ttm) 0.05
PE Ratio 134.27
Forward PE n/a
Dividend $0.25 (3.77%)
Ex-Dividend Date Feb 14, 2025
Volume 18
Open 6.66
Previous Close 6.25
Day's Range 6.64 - 6.66
52-Week Range 5.75 - 9.50
Beta 0.69
Analysts Strong Buy
Price Target 8.50 (+28.01%)
Earnings Date Apr 14, 2025

About CCEL

Cryo-Cell International, Inc. engages in cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells, which are used in regenerative medicine to treat a range of conditions. The company manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell pr... [Read more]

Sector Healthcare
IPO Date Jan 21, 1997
Employees 86
Stock Exchange NYSEAMERICAN
Ticker Symbol CCEL
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecast

According to one analyst, the rating for CCEL stock is "Strong Buy" and the 12-month stock price forecast is $8.5.

Price Target
$8.5
(28.01% upside)
Analyst Consensus: Strong Buy
Stock Forecasts

News

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2024

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced r...

4 weeks ago - Business Wire

Cord Blood Banking Leader Cryo-Cell Announces Regular Quarterly Cash Dividend and Pause of Strategic Initiatives

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (“Cryo-Cell”), the world's first private cord blood bank to separate and store stem cells in 1992, announ...

2 months ago - Business Wire

Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (“Cryo-Cell”), the world's first private cord blood bank to separate and store stem cells in 1992, announ...

5 months ago - Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, anno...

6 months ago - Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2024 Financial Results

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced r...

9 months ago - Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced ...

1 year ago - Business Wire

Cryo-Cell Announces Plans to Explore Strategic Alternatives and Spin-off Celle Corp. to Maximize Shareholder Value

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company” or “Cryo-Cell”), the world's first private cord blood bank to separate and store stem cells in 19...

1 year ago - Business Wire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2023

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced r...

1 year ago - Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2023 Financial Results

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, anno...

1 year ago - Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2023 Financial Results

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced r...

1 year ago - Business Wire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2023 Financial Results

OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced ...

2 years ago - Business Wire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2022

OLDSMAR, Fla., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (NYSE American LLC: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in ...

2 years ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2022 Financial Results

OLDSMAR, Fla., Oct. 14, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem ce...

2 years ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Special Cash Dividend

OLDSMAR, Fla., Aug. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”), the world's first private cord blood bank to separate and store ste...

2 years ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Transfer to the NYSE American Stock Exchange

OLDSMAR, Fla., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (“Cryo-Cell”, the “Company”), the world's first private cord blood bank to separat...

2 years ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Second Quarter 2022 Financial Results

OLDSMAR, Fla., July 11, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...

2 years ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2022 Financial Results

OLDSMAR, Fla., April 13, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (OTC:QB Markets Group Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ste...

3 years ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Announces Extravault Biorepository Service

OLDSMAR, Fla., March 16, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ...

3 years ago - GlobeNewsWire

Cryo-Cell Shares Its 2021 Annual Letter to Shareholders

OLDSMAR, Fla., March 09, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store ...

3 years ago - GlobeNewsWire

Cryo-Cell Reports Financial Results for Fiscal Year Ended November 30, 2021

OLDSMAR, Fla., Feb. 22, 2022 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...

3 years ago - GlobeNewsWire

Cryo-Cell International: A Stable Business Paired With An Upcoming Catalyst

Cryo-Cell International has a stable business that generates consistent cash flow. The company is close to monetizing a partnership with Duke University to bring patented stem cell treatments to marke...

3 years ago - Seeking Alpha

Cord Blood Banking Leader Cryo-Cell Announces Its Intent to Advance Clinical Trials

OLDSMAR, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...

3 years ago - GlobeNewsWire

Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2021 Financial Results

OLDSMAR, Fla., Oct. 15, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (The Nasdaq Stock Market Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store s...

3 years ago - GlobeNewsWire

Cryo-Cell International Announces Changes To Its Board of Directors

MIAMI, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Cryo-Cell International, Inc. (Nasdaq:CCEL), the leader in cord blood and cord tissue cryopreservation services, announces the appointment of Mr. Mark Portnoy...

3 years ago - GlobeNewsWire

Cryo-Cell International Announces Uplisting to The Nasdaq Capital Market

Cryo-Cell International, Inc. (Symbol CCEL), The Leader In Cord Blood And Cord Tissue Cryopreservation Services, Today Announced That The Company's Common Stock Has Been Approved For Listing On The Na...

3 years ago - GlobeNewsWire